Related Experiment Video
Updated: Apr 15, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Tannins as Therapeutic Agents for Ulcerative Colitis: Mechanisms and Prospects in Regulating Gut
Yanling Li1, Can Sun1, Fuqi Hao2
1College of Pharmacy, North Henan Medical University, Xinxiang 453003, China.
Abstract:
Ulcerative colitis (UC) is a multifactorial disease characterized by chronic intestinal inflammation and disrupted oxidative balance, significantly impairing patients' quality of life. Tannins, a class of polyphenolic compounds widely distributed in plants, have demonstrated notable therapeutic potential against UC due to their inherent antioxidant and anti-inflammatory properties. This study employs a systematic literature review of databases, including PubMed and Web of Science, to investigate the molecular mechanisms by which tannins restore intestinal inflammatory and oxidative homeostasis. The findings indicate that tannins directly scavenge reactive oxygen species (ROS) via their polyphenolic structure, mitigate oxidative damage, upregulate antioxidant enzyme expression, suppress pro-inflammatory cytokine secretion, and preserve intestinal barrier integrity. Despite their significant therapeutic promise, challenges such as low bioavailability and structural complexity remain. Future research should prioritize bioavailability enhancement, clarification of structure-activity relationships, and translational studies to facilitate the clinical application of tannin-based therapies for UC.
Insights
Tannins show promise for ulcerative colitis (UC) by reducing inflammation and oxidative stress. Further research is needed to improve tannin bioavailability for effective UC treatment.
Area of Science:
- Gastroenterology
- Pharmacology
- Natural Products Chemistry
Background:
- Ulcerative colitis (UC) involves chronic intestinal inflammation and oxidative imbalance, impacting patient quality of life.
- Tannins, plant-derived polyphenols, possess antioxidant and anti-inflammatory properties with therapeutic potential for UC.
Purpose of the Study:
- To systematically review the molecular mechanisms of tannin action in restoring intestinal homeostasis in UC.
- To explore the potential of tannins as a therapeutic strategy for ulcerative colitis.
Main Methods:
- Systematic literature review of PubMed and Web of Science databases.
- Analysis of studies investigating tannin effects on oxidative stress and inflammation in UC models.
Main Results:
- Tannins scavenge reactive oxygen species (ROS) and mitigate oxidative damage through their polyphenolic structure.
- Tannins upregulate antioxidant enzymes, suppress pro-inflammatory cytokines, and maintain intestinal barrier integrity.
- Evidence suggests tannins can restore intestinal inflammatory and oxidative homeostasis.
Conclusions:
- Tannins exhibit significant therapeutic promise for ulcerative colitis by targeting key inflammatory and oxidative pathways.
- Challenges including low bioavailability and structural complexity require further investigation for clinical translation.
- Future research should focus on enhancing bioavailability and clarifying structure-activity relationships for tannin-based UC therapies.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

